•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
Burning Rock Biotech joins hands with Bayer to expand precision cancer therapies portfolio
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
Q1 2024 Burning Rock Biotech Ltd Earnings Call Transcript
Burning Rock Biotech Aims for 2024 Breakeven
Burning Rock Biotech GAAP EPS of -$0.16, revenue of $17.4M
Burning Rock Biotech Announces Q1 Results Date
Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
Burning Rock Publishes 2023 Annual Report on Form 20-F
Burning Rock Publishes 2023 Annual Report on Form 20-F
Burning Rock Biotech Files 2023 Annual Report
Burning Rock Announces ADS Ratio Change
Burning Rock Announces ADS Ratio Change
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Recent
price
P/E
ratio
div
yld
- -
ROIC.AI